Literature DB >> 12427157

Hypertension as a determinant of survival for patients treated with home dialysis.

Kelvin L Lynn1, David O McGregor, Todd Moesbergen, Adrian L Buttimore, Judith A Inkster, J Elisabeth Wells.   

Abstract

BACKGROUND: Previous studies of the risks of hypertension for dialysis patients have yielded conflicting results. The aim of this study was to investigate, in a home dialysis population with low rates of diabetes and antihypertensive drug use, whether blood pressure (BP) was an independent risk factor for survival.
METHODS: The outcome of 168 consecutive patients (94 male, 88% Caucasian), aged 48 years (SD 16), who began home hemodialysis (HD; N = 124) or home continuous ambulatory peritoneal dialysis (CAPD; N = 44) between January 1, 1985 and December 31, 1994 were analyzed retrospectively. Only 4.7% of patients took antihypertensive drugs while on dialysis. The patients were followed to December 31, 1998 with the primary outcome being all-cause mortality. Censoring events were transplantation, transfer to another center and treatment modality change. The Cox proportional hazard model was used with baseline predictors.
RESULTS: Seventy-one patients died and the median overall survival was 4.2 years (5.6 on HD, 2.2 on CAPD, P < 0.0001). Mean BP at start of dialysis predicted survival on its own (P = 0.0009) and in the joint Cox model (P = 0.047). Other significant predictors in the joint model were age [10 year increase, relative hazard (RH) = 1.55, P = 0.0008], albumin (10 g/L decrease, RH = 2.05, P = 0.007), diabetes (RH = 3.42, P = 0.015) and peripheral vascular disease (RH = 2.19, P = 0.02) but not dialysis modality (RH = 1.63, P = 0.13). High and low mean blood pressure (BP) values at the start of dialysis were associated with the highest mortality.
CONCLUSIONS: Among the home dialysis patients, most of whom did not require antihypertensive drugs, hypertension was a risk factor for survival and patients with mid-range BP values survived the longest.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427157     DOI: 10.1046/j.1523-1755.2002.00685.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

Review 1.  Improved blood pressure control with nocturnal hemodialysis: review of clinical observations and physiologic mechanisms.

Authors:  Brendan B McCormick; Christopher T Chan
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

2.  Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease.

Authors:  Miklos Z Molnar; Lilia R Lukowsky; Elani Streja; Ramanath Dukkipati; Jennie Jing; Allen R Nissenson; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  J Hypertens       Date:  2010-12       Impact factor: 4.844

3.  Association of body mass index and uncontrolled blood pressure with cardiovascular mortality in peritoneal dialysis patients.

Authors:  Wei Li; Ricong Xu; Yating Wang; Jiani Shen; Zhijian Li; Xueqing Yu; Haiping Mao
Journal:  J Hum Hypertens       Date:  2018-09-12       Impact factor: 3.012

4.  Reverse Epidemiology of Blood Pressure in Peritoneal Dialysis Associated with Dynamic Deterioration of Left Ventricular Function.

Authors:  Farsad Afshinnia; Ziad S Zaky; Manasa Metireddy; Jonathan H Segal
Journal:  Perit Dial Int       Date:  2015-08-20       Impact factor: 1.756

Review 5.  Blood Pressure and Mortality in Long-Term Hemodialysis-Time to Move Forward.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Am J Hypertens       Date:  2017-03-01       Impact factor: 2.689

6.  The management of hypertension in hemodialysis and CAPD patients.

Authors:  M Malliara
Journal:  Hippokratia       Date:  2007-10       Impact factor: 0.471

7.  Association of pre-transplant blood pressure with post-transplant outcomes.

Authors:  Miklos Z Molnar; Clarence E Foster; John J Sim; Adam Remport; Mahesh Krishnan; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Clin Transplant       Date:  2013-12-24       Impact factor: 2.863

Review 8.  Target blood pressure in patients with end-stage renal disease: evidence-based medicine or the emperor's new clothes?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-05       Impact factor: 3.738

9.  Back to basics: pitting edema and the optimization of hypertension treatment in incident peritoneal dialysis patients (BRAZPD).

Authors:  Sebastião R Ferreira-Filho; Gilberto R Machado; Valéria C Ferreira; Carlos F M A Rodrigues; Thyago Proença de Moraes; José C Divino-Filho; Marcia Olandoski; Christopher McIntyre; Roberto Pecoits-Filho
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

10.  The Optimal Blood Pressure Target in Different Dialysis Populations.

Authors:  Jong Hyun Jhee; Jimin Park; Hyoungnae Kim; Youn Kyung Kee; Jung Tak Park; Seung Hyeok Han; Chul Woo Yang; Nam-Ho Kim; Yon Su Kim; Shin-Wook Kang; Yong-Lim Kim; Tae-Hyun Yoo
Journal:  Sci Rep       Date:  2018-09-20       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.